The total return over the past 12 months is -2.48% vs. +16.94% for the S&P 500. So far it's up -33.14% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (2.48%) | +33.85% | (10.66%) | (13.41%) | (18.97%) | N/A |
| Total Return CAGR | (2.48%) | +33.85% | (10.66%) | (13.41%) | (18.97%) | N/A |
| Revenue CAGR | +125.12% | N/A | (1.78%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Assembly Biosciences, Inc. (ASMB)
| Year | Start price | End price | ASMB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $34.01 | $22.74 | (33.14%) | +14.51% | (47.65%) |
| 2025 | $15.78 | $34.01 | +115.53% | +17.72% | +97.81% |
| 2024 | $9.84 | $15.78 | +60.37% | +24.89% | +35.48% |
| 2023 | $15.60 | $9.84 | (36.92%) | +26.19% | (63.11%) |
| 2022 | $27.96 | $15.60 | (44.21%) | (18.17%) | (26.04%) |
| 2021 | $72.60 | $27.96 | (61.49%) | +28.74% | (90.23%) |
| 2020 | $245.52 | $72.60 | (70.43%) | +18.37% | (88.80%) |
| 2019 | $271.44 | $245.52 | (9.55%) | +31.22% | (40.77%) |
| 2018 | $543.00 | $271.44 | (50.01%) | (4.56%) | (45.45%) |
| 2017 | $145.80 | $543.00 | +272.43% | +21.70% | +250.73% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
